| Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus. | |
| | |
MedLine Citation:
|
PMID: 7865979 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Nephrogenic diabetes insipidus (NDI) is a serious side effect of various drugs. Elevated renal prostaglandin E2 levels have been found in patients with lithium-induced NDI and have been implicated in the pathogenesis. We report the case of a patient who developed NDI following treatment with amphotericin B. Prostaglandin levels were elevated. Indomethacin had an antidiuretic effect and normalized prostaglandin levels. |
| | |
Authors:
|
T Höhler; G Teuber; R Wanitschke; K H Meyer zum Büschenfeld |
Related Documents
:
|
21831469 - Diabetic hand syndromes as a clinical and diagnostic tool for diabetes mellitus patients. 21677039 - Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the youn... 20888099 - A history of diabetes insipidus: paving the road to internal water balance. 22247979 - A case of hypoglycemic hemiparesis and literature review. 9756089 - Aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus. 10437189 - Clinical observation of chinese drugs in prevention of neonatal hyperbilirubinemia. 183599 - The control of glycogen metabolism in the liver. 6126999 - Effect of somatostatin on insulin-induced hypoglycemia in man. 3307259 - Continuous subcutaneous insulin infusion (csii) in the management of diabetic lipodystr... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: The Clinical investigator Volume: 72 ISSN: 0941-0198 ISO Abbreviation: Clin Investig Publication Date: 1994 Oct |
Date Detail:
|
Created Date: 1995-03-28 Completed Date: 1995-03-28 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9207154 Medline TA: Clin Investig Country: GERMANY |
Other Details:
|
Languages: eng Pagination: 769-71 Citation Subset: IM |
Affiliation:
|
I. Medizinische Klinik und Poliklinik, Johannes Gutenberg Universität Mainz, Germany. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amphotericin B
/
adverse effects* Diabetes Insipidus, Nephrogenic / chemically induced*, drug therapy Diuresis / drug effects Female Humans Indomethacin / pharmacology, therapeutic use* Kidney / metabolism Leukemia, Myelomonocytic, Acute / complications Middle Aged Prostaglandins / metabolism* Tobramycin / adverse effects Vasopressins / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Prostaglandins; 11000-17-2/Vasopressins; 1397-89-3/Amphotericin B; 32986-56-4/Tobramycin; 53-86-1/Indomethacin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Impact of long-term hemodialysis on nutritional status in patients with end-stage renal failure.
Next Document: Localization of the bronchodilator effect induced by type A natriuretic peptide in asthmatic subject...